---
title: 'Simultaneous removal of endotoxins, inflammatory mediators and uremic toxins
  in ICU patients with septic shock: a retrospective cohort study'
date: '2024-08-23'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39179637/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240824182422&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: Sepsis, one of the leading causes of death, is still lacking specific
  treatment. OXIRIS (BAXTER, Deerfield, IL, USA) is the first device allowing combined
  removal of endotoxins, inflammatory mediators and uremic toxins, alongside fluid
  balance control. Available data is very limited. This retrospective propensity score-matched
  cohort study of adult patients with septic shock aimed to evaluate septic shock
  duration and mortality in patients treated with either standard of care renal ...
disable_comments: true
---
Sepsis, one of the leading causes of death, is still lacking specific treatment. OXIRIS (BAXTER, Deerfield, IL, USA) is the first device allowing combined removal of endotoxins, inflammatory mediators and uremic toxins, alongside fluid balance control. Available data is very limited. This retrospective propensity score-matched cohort study of adult patients with septic shock aimed to evaluate septic shock duration and mortality in patients treated with either standard of care renal ...